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The World Anti-Doping Agency (WADA) prohibits the use of anabolic-androgenic steroids 
(AAS) in sport. Despite this prohibition, AAS remains the most prevalent class of compound 
confirmed in anti-doping samples by WADA-accredited laboratories [1]. Among the most popular 
and widely detected AAS are nandrolone (N) and testosterone (T), which are prohibited at all 
times, both in and out of competition [2].  
 
Unfortunately for anti-doping analysis, both of these AAS are pseudo-endogenous as they may also 
be present naturally. Evidence of N misuse primarily relies on the presence in an athlete’s urine of 
one of its main metabolites, 19-norandrosterone (19-NA), as a consequence of the rapid 
metabolism of nandrolone [3, 4]. However, WADA stipulates that urinary 19-NA concentration 
between 2.5 to 15 ng/mL be subjected to further confirmatory analysis [5]. This is because small 
amounts of 19-NA may be present naturally or formed as degradation products post-sample 
collection in the urine of males [ 3 ,  6 ]  as well as females (especially during pregnancy and 
ovulation or following norethisterone contraception) [7]. The endogenous production of 19-NA is 
believed to be a result of the biotransformation of androgens to estrogens by aromatase enzymes [7, 
8]. Therefore, detection of small amounts of 19-NA may not be sufficient proof of administration 
unless the origin of the compound can be determined [5, 7, 8]. 
 
The case for T administration is similarly complicated due to the large variation in inter-
individual urinary T concentrations (and the concentrations of its metabolites). 
 
Gas chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) is the established  
confirmation procedure used by WADA accredited laboratories to distinguish the origin or source 
of urinary steroids by means of carbon isotope ratio (13C/12C) analysis with values expressed in 
delta (δ) units referenced to the Vienna Pee Dee Belemnite international standard [9, 10]. 
 
Synthetic or pharmaceutically-produced steroids are frequently synthesized from soy derived 
precursors produced by plants, which discriminate significantly against 13C during carbon fixation. 
As a result, synthetically derived steroids typically have a more negative δ13C value (range: -27 to 
-34 ‰) in comparison to normally observed values for endogenous steroids produced by humans 
(range: -16 to -26 ‰) [11]. The range of 13C content, and hence measured δ13C, for endogenous 
steroids is a consequence of an individual’s diet, which consists of a range of plant and animal 
sources with varying 13C content [11-13]. 
 
In anti-doping analysis, WADA requires the δ13C value of the target steroid (this may be the 
administered steroid or a metabolite of the administered steroid) to be compared with that of an 
endogenous reference compound (ERC) [14]. The ERC (e.g. pregnanediol or 11-keto-
etiocholanolone) is a steroid eliminated in urine that is metabolically distinct from the target steroid 
and therefore not influenced by the administration of the synthetic steroid. As such, its delta value 
can be considered representative of an individual’s diet and metabolism. Following steroid 
administration, a significant δ13C difference (Δδ) (typically more than 3 ‰) may be observed 
between ERC and target steroid and can thus be used to confirm administration [15, 16]. 
 
However, GC-C-IRMS analysis will be inconclusive if the administered steroid has a similar δ13C 
value to that from endogenous steroids. Due to this possibility, many investigations have been 
conducted on various commercially-available synthetic steroid products (both legitimate and illicit), 
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to determine if their δ13C values overlap with those values seen for naturally-produced steroids. 
Hullstein et al. [17] analysed N and T preparations seized in Norway (range -24 to -32 ‰); 
Forsdahl et al. [18] analysed black market T products collected in Austria (range -23 to -29 ‰); 
and Cawley et al. [19] profiled legitimate pharmaceutical and veterinary T products plus illicit T 
preparations obtained in Australia (range -22 to -32 ‰). To the best of our knowledge, there has 
been no publication on δ13C values of steroid products in the UK market. Therefore, we decided to 
undertake a similar study to investigate the availability of synthetic steroid preparations in the UK 
that have δ13C values similar to those of endogenous steroids. Fourteen different N and T 
preparations obtained from UK pharmacies and custom authorities were analysed to determine 





Chemicals and Reagents 
 
All reagents and solvents were of analytical grade. Methanol, ethyl acetate, methyl-tert- butyl-
ether (MTBE), hydrochloric acid (HCl) and potassium hydroxide (KOH) were purchased from 
Fisher Scientific (Loughborough, UK). Ammonium iodide (NH4I) was purchased from VWR 
International (Lutterworth, UK). Testosterone, Octacosane, dodecane, N-methyl-N-
trimethylsilyl-trifluoroacetamide (MSTFA), acetic anhydride, pyridine and ethanethiol were 
purchased from Sigma Aldrich (Poole, UK). Reference nandrolone was obtained from LGC 
standards (Teddington UK). Purified water was obtained from ELGA Purelab Maxima (Vivendi 




A total of 14 steroid preparations (see Table 1) were analysed. Six were pharmaceutical-grade 
products purchased from UK pharmacies. The other 8 (seized preparations) were provided by the 
UK custom authorities through UK Anti-Doping. 
 
Preparation of steroid sample stock solution 
 
Stock solutions of each steroid (250 µg/mL of the ester) were prepared in methanol.  
 
Sample preparation for identification of steroid esters by GC-MS 
 
For identification purposes 10 µL of each steroid stock solution was transferred into a glass tube 
and evaporated to dryness at 60 ºC for 5 min under nitrogen. Derivatization was carried out by 
adding 40 µL of the derivatizing solution (MSTFA:NH4I:ethanethiol, 1000:3:9, v/w/v) to the dried 
residue, and heating at 60 ºC for 20 min. Once cooled to room temperature, a suitable volume of 
dodecane was added to yield an (estimated in the case of bulk powders) steroid concentration of 
25 µg/mL for GC-MS analysis. 
 
Sample preparation for δ13C value determination of free steroids by GC-C-IRMS 
 
A method adapted from Forsdahl et al. [18] was used. Briefly, 20 µL of steroid stock solution was 
diluted with 480 µL water. To cleave the esters a hydrolysis step was carried out by adding 1.5 mL 
of KOH (2 M), and the solution incubated for 2 hours at 60 ºC. The solution was neutralized by 
adding 1.5 mL of HCl (1 M). Isolation of free steroids was performed using liquid-liquid 
extraction with MTBE (3 x 2 mL). The combined organic fraction was evaporated to dryness at 60 
ºC for 20 min under nitrogen. For the derivatization step, 50 µL acetic anhydride and 50 µL 
pyridine were added to the dried residue and the solution incubated at 80 ºC for 2 hours, followed 
by evaporation to dryness at 60 ºC for 20 min under nitrogen. A suitable volume of ethyl acetate 
was added to yield a signals within the working range of the instrument, with a target signal of 




Gas chromatography mass spectrometry (GC-MS) 
 
Identification of steroid esters was performed using an Agilent GC-MS (Santa Clara, USA) 
instrument equipped with an automatic sampler, a 7890A gas chromatograph and a 5975C mass 
selective detector (MSD). Injection port temperature was 280 °C and the sample (1 µL) was injected 
in splitless mode. Helium was used as the carrier gas with a flow rate of 0.7 mL/min. 
Chromatographic separation was performed using an Agilent HP-1 capillary column (25 m length x 
200 µm internal diameter x 0.11 µm film thickness). The oven temperature programme was 180 °C 
(1 min), 8 °C/min to 220 °C (0 min), 3 °C/min to 250 °C (0 min) and 14 °C/min to 320 °C (10 min) 
for a total run time of 31 min. MSD transfer line was set at 280 °C, MS ion source at 230 °C, and 
MS quadrupole at 150 °C. The MSD was operated in electron ionization mode at 70 eV, with full 
scan acquisition (mass range m/z 80-800). 
 
Gas chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) 
 
The carbon isotope ratio measurements were performed on a Delta V Plus Isotope Ratio MS 
(ThermoFisher Scientific, Bremen, Germany) coupled to an Agilent 7890A Gas Chromatograph, 
with a multi-purpose autosampler (GERSTEL GmbH & Co.KG, Germany). Volume of injection is 
50 µL using PTV (programmable temperature vaporization) inlet, with a total flow of 154.3 
mL/min at 16.4 psi. Chromatographic separation was performed on an Agilent HP-50+ capillary 
column (50 %-phenyl-methylpolysiloxane, 30 m length x 250 µm i.d., 0.25 µm film thickness). 
The initial oven temperature was set at 80 ºC for 1.5 min, then increased at 30 ºC/min to 250 ºC, 
followed by 4.5 ºC/min to 300 ºC and held for 5 min, for a total run time of 23.27 min. Helium was 
used as carrier gas at a flow rate of 1.3 mL/min. The outlet of the GC column was split between an 
Agilent MSD 5975C and the IRMS combustion furnace (1:9 ratio), which allowed simultaneous 
acquisition of full scan mass spectra and IRMS data of eluting analytes. The MSD was operated 
in full scan acquisition (mass range m/z 40-450). MS source and quadrupole temperatures were 
230 ºC and 150 ºC respectively. The IRMS combustion furnace was set to 950 ºC, with copper 
oxide as the oxygen source. H2O was removed via a Nafion® membrane. In each analysis run, 
CO2 reference gas was pulsed eight times (20 s duration), five at the start and three at the end of 
the run. The acquisition time for the IRMS was extended beyond that of the GC to 26.7 
minutes, which allowed the CO2 reference gas pulses to be obtained at the end of the run while 
the GC was cooling down, therefore decreasing the overall runtime. To account for the shift of 
δ13C values due to the acetyl moiety introduced during derivatization, a mass balance approach 
was used [14]. 
 
IRMS system suitability checks: stability and linearity 
 
Prior to each batch of samples, a stability test for the instrument was performed by pulsing the 
CO2 reference gas 10 times at the same intensity (5,500 mV at m/z 44). To test the IRMS 
instrument linearity, CO2 gas was pulsed automatically by the system 7 times over a range of 




For every batch, positive (N and T reference standard) and negative (water blank extract) controls 
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were included. Laboratory-calibrated 13C/12C isotopic standard (octacosane, δ13C = -29.6  ‰) was 
added in each sample vial as an internal isotopic standard to assess the accuracy of the acquired 
δ13C values. The CO2 reference cylinder itself was calibrated using certified hydrocarbon 
standards (octacosane and dotriacontane) obtained from Chiron (Trondheim, Norway), and 
USADA standards (35-1 and 34-2) containing androsterone, etiocholanolone, 5α-androstanediol, 
5β-androstanediol and pregnanediol (2 sources), each measured 10 times. The delta value of the 
CO2 reference cylinder was set such that the mean difference for all six certified standards 
between the obtained and certified values was zero.  The δ13C values for all of the steroid 
preparations were each measured 6 times, and the mean and standard deviation (s.d.) calculated. 
After every 6 samples injections in each batch, N or T standards were introduced to assure the 
quality of the analytical measurement. Data acceptance criteria were: retention time of steroid 
within +0.1 min of retention time of corresponding standard and a minimum 1,000 mV response at 
m/z 44 to ensure reliability of δ13C measurements. 
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RESULTS AND DISCUSSION 
 
This study consisted of two main steps: The qualitative identification of steroid esters (as TMS 
derivatives) by GC-MS, followed by the determination of their carbon isotope ratio by GC-C-




All steroids were successfully identified using the applied methodology. As may be expected, all 
steroids obtained as pharmaceutical preparations contained the expected steroid in ester form. 
Interestingly, the seized steroids were also all shown to contain the expected steroid, based on the 
limited information available. For example, several bulk powders simply labelled as NPP were 
found to contain nandrolone phenylpropionate. No preparation was found to contain significant 




The measured δ13C values for the laboratory steroid reference standards (mean ±s.d.) were 
-30.2 ±0.8 ‰ (n=10) for N and -30.6 ±0.3 ‰ (n=5) for T which were comparable with values of 
pharmaceutical-grade steroid standards reported in the literature (range: -29.7 to -30.0 ‰) [14, 
18]. 
 
The octacosane standard analyzed with each sample injection had a mean δ13C value of -29.3 
±0.6 ‰ (n=84). This is not statistically significant (one sample t-test, p > 0.05) compared to the 
laboratory-assigned value (-29.6 ‰). The range of standard deviation (0.2 - 0.9 ‰, see Table 1) 
for the replicate injections of unknown steroid samples was within the precision associated with 
GC-C-IRMS analysis under the specified conditions (<1.0 ‰) [10, 19]. All δ13C values for steroids 
reported in this manuscript are for the free steroid, with correction for the influence of the acetate 
moiety done using a mass balance approach [14]. 
 
As GC–C–IRMS analysis involves combustion of a target substance to form CO2, no spectral 
information is available to facilitate analyte identification and help identify interfering peaks [10]. 
Splitting of GC eluents into the MSD and IRMS alleviates this problem by allowing simultaneous 
acquisition of full scan mass spectra of chromatographic peaks along with isotope ratio analysis 
[20]. This step is also important to monitor co-elution of interferents with the target steroids 
which, if present, may alter the measured carbon isotope value. All chromatograms were found to 
be free of interfering compounds, with an example of the GC-C-IRMS chromatogram presented in 
Figure 1 and the simultaneously-acquired GC-MS data presented in Figure 2. Additional peaks in 
the chromatogram where not identified but are likely to result from both the steroid preparation 
analysed but further work was not performed as it was beyond the scope of the project. 
 
δ13C values of nandrolone and testosterone preparations 
 
Table 1 shows the δ13C values of the N and T preparations analysed in this study. All the products 
acquired from pharmacies displayed δ13C values (range -27.9 to -32.7 ‰) within the expected range 
of synthetic steroid preparations (less than -27 ‰) and can therefore be considered consistent with 
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production from soy or a similar source. This range was also similar to those reported in other 
studies investigating legitimate pharmaceutical preparations, i.e. -27.0 to -28.4 ‰ [21], -27.6 to -
30.6 ‰ [22] and -27.4 to -31.8 ‰ [19]. 
 
 
As highlighted in Table 1, four N preparations showed δ13C values in the endogenous range, all 
corresponding to preparations that were seized by UK custom authorities. In contrast, a similar 
investigation by Hullstein et al. [17] on N preparations (n = 22) seized in Norway demonstrated 
that almost all δ13C values appeared in the exogenous range (< -27.0 ‰), with only one 
preparation identified to be close to the endogenous range (-26.7 ‰). These “endogenous-like” 
preparations are unlikely to result from soy plant derived precursors, or indeed any other plant 
material which uses the same photosynthetic pathway (C3). An alternative source material for these 
steroids may be that they are derived from sisal. Sisal (Agave sisalana) is a widely grown cash crop 
originating in Mexico but now prevalent all over the world. Steroids derived from plants use 
sapogenins as the starting material and hecogenin, a sapogenin available in large quantities from 
the waste of sisal plants is known to be used for synthesis of cortisol [23, 24]. This is particularly 
important as sisal unlike most plants does not use the C3 (or indeed C4) photosynthetic pathway 
but instead uses the crassulacean acid metabolism (CAM) pathway. This photosynthetic 
mechanism results in less discrimination of 13C during carbon fixation and therefore will produce 
delta values that are less negative than soy-derived steroids but more like those observed for the 
four “endogenous-like” N preparations seen in this study. Though little research has been done on 
the carbon isotope ratio signature of sisal plants, research on the carbon delta value of other CAM 
plants such as pineapple has been undertaken and offers some support to the hypothesis proposed 
here [25]. 
 
None of the T preparations in this study had δ13C values within the endogenous range. Though this 
is in contrast to the published data, it has to be considered that this may be a consequence of the 
small sample size in this study (n = 5) and the fact that four of the five preparations were 
sourced from pharmacies [17-19, 22] 
 
In doping-control analysis, detecting the misuse of steroids produced naturally by humans (i.e. T 
and 19-NA) is regarded as one of the most challenging tasks due to the difficulty in proving their 
administration [12]. The availability of synthetic T and N preparations with endogenous δ13C 
values on the market as has been shown in this study and those of others [17-19, 22] further 
complicates substantiating evidence of their misuse. This is because, if these steroid preparations 
are administered, analysis by GC-C-IRMS will yield urinary steroids exhibiting δ13C values that 
cannot be differentiated from endogenous origin. Based on WADA guidelines, this may be 
reported as an inconclusive or atypical finding rather than an adverse analytical finding [5, 14, 26]. 
Other factors such as steroid dosage and timing of urine collection post-administration [22] could 
also influence a negative or positive outcome since the δ13C value will normalize to the athlete’s 
baseline level after a washout time, that is either a normalisation of the δ13C value back to 
endogenous in the case of T  [27] or a reduction in 19-NA concentration such that it is below the 
measurement capability of the assay. 
 
On the other hand, misuse of steroid preparations that have δ13C values further into the exogenous 
range (less than -29 ‰) remain easy to detect. For instance, administration of the most 13C-depleted 
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products (-32.7 ‰) represent the most likely to yield positive results by GC-C-IRMS analysis as 




In conclusion, analysis of δ13C values for fourteen preparations containing N and T revealed that 
four N preparations, all seized material, displayed a δ13C value that overlaps with the values 
measured for endogenous steroids (range -26 to 16 ‰). Administration of these preparations 
would be challenging to prove from a doping-control context because the corresponding urinary 
metabolites would exhibit δ13C values within the range of endogenous steroids, hence yielding a 
negative or inconclusive result by GC-C-IRMS analysis. It may be that the analysis of additional 
isotope signatures, such as hydrogen may offer improved discrimination but this will require 
further research. In such cases, the timing of sample collection would need to be close to 
administration of the N preparation to detect the parent compound rather than rely on such 
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Figure 1: GC-C-IRMS chromatogram of nandrolone preparation #9 (b), in its acetylated form. The 
top trace shows the ratio of m/z 45/44. The bottom trace (m/z 44) shows the chromatogram peaks 





Figure 2: The corresponding GC-MS chromatogram & mass spectrum of nandrolone preparation 
#9 (b), in its acetylated form. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
